Iovance Biotherapeutics Inc
SWB:2LB
Iovance Biotherapeutics Inc
SWB:2LB
Price:
3.445
EUR
-1.01%
Market Closed
Market Cap:
€964m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Iovance Biotherapeutics Inc
SWB:2LB
|
US |
|
A
|
Ares Commercial Real Estate Corp
F:41I
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
DUS:PJXA
|
BR |
|
T
|
Telefonaktiebolaget LM Ericsson
F:ERCB
|
SE |
|
Pepkor Holdings Ltd
F:S1VA
|
ZA |
|
Zepp Health Corp
NYSE:ZEPP
|
CN |
|
C
|
California Water Service Group
F:WT5
|
US |
|
G
|
Grupo Aeroportuario del Centro Norte SAB de CV
XMUN:G7A
|
MX |
|
Cherry SE
F:C3RY
|
DE |
|
A
|
Atlas Arteria Group
F:M82
|
AU |
|
S
|
Standard Chartered PLC
SWB:STD
|
UK |
|
S
|
Siemens Healthineers AG
DUS:SHL
|
DE |
|
D
|
Douglas Dynamics Inc
F:5D4
|
US |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
Vince Holding Corp
NASDAQ:VNCE
|
US |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XHAM:TKD
|
JP |
Wall St Price Targets
2LB Price Targets Summary
Iovance Biotherapeutics Inc
Iovance Biotherapeutics Inc
Wall Street analysts forecast 2LB stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 2LB is 7.827 EUR with a low forecast of 3.445 EUR and a high forecast of 14.324 EUR.
Lowest Forecast
Price Target
3.445
EUR
0% Downside
Average Forecast
Price Target
7.827
EUR
127% Upside
Highest Forecast
Price Target
14.324
EUR
316% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2LB's stock price target?
Price Target
7.827
EUR
7.827
EUR
According to Wall Street analysts, the average 1-year price target for 2LB is 7.827 EUR with a low forecast of 3.445 EUR and a high forecast of 14.324 EUR.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
18%
18%
The compound annual growth rate for Revenue over the next 8 years is 18%.
